Accuray Incorporated Accuray Incorporated

Accuray Incorporated

ARAY

Rank in Stocks #28332
Accuray Incorporated specializes in the design, development, production, and... Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver highly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.
Share Price
$3.82
Last synced: 2026-11-09
Market Cap
$11.48M
Change (1 day)
3,372.73%
Change (1 year)
226.50%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Accuray Incorporated (ARAY)
EPS as of September 2026 TTM: $-0.15
According to Accuray Incorporated's latest financial reports, its current EPS (TTM) is $-0.15. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.16.
EPS history for Accuray Incorporated from 2002 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.15 650.00%
2025 $-0.02 -90.31%
2024 $-0.16 63.60%
2023 $-0.10 68.33%
2022 $-0.06 -15.31%
2021 $-0.07 -261.03%
2020 $0.04 -122.42%
2019 $-0.19 -32.14%
2018 $-0.28 -22.22%
2017 $-0.36 12.50%
2016 $-0.32 -37.25%
2015 $-0.51 8.51%
2014 $-0.47 -66.67%
2013 $-1.41 38.24%
2012 $-1.02 131.82%
2011 $-0.44 -990.69%
2010 $0.05 349.09%
2009 $0.01 -88.86%
2008 $0.10 -154.83%
2007 $-0.18 -91.47%
2006 $-2.11 19.89%
2005 $-1.76 76.00%
2004 $-1.00 -32.89%
2003 $-1.49 23.14%
2002 $-1.21 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$2.70 -1,900.00%
US
$4.09 -2,826.67%
IE
$9.45 -6,400.00%
US
$2.37 -1,680.00%
US
$1.77 -1,280.00%
US

Questions about Accuray Incorporated's earnings per share (EPS)

What is Accuray Incorporated's earnings per share (EPS)?

Accuray Incorporated's earnings per share (EPS) over the last twelve months is $-0.15, as of Sep 2026.

What was Accuray Incorporated's earnings per share (EPS) in 2025?

In 2025, Accuray Incorporated's earnings per share (EPS) was $-0.02, compared with $-0.16 in 2024.

How has Accuray Incorporated's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Accuray Incorporated's earnings per share (EPS) was highest in 2020 ($0.04) and lowest in 2024 ($-0.16).

How does Accuray Incorporated's earnings per share (EPS) compare with similar companies?

Accuray Incorporated's earnings per share (EPS) ($-0.15) is lower than that of all 5 similar companies listed above. The highest among them is Stryker Corporation, with $9.45.